Key result
Single-stage minimally invasive resection of left atrial myxoma and pulmonary carcinoid proves feasible at 36 months.
Why the study?
Synchronous primary cardiac and pulmonary tumors are rare and present complex therapeutic challenges regarding surgical sequencing and perioperative risk.
Case Report (n=1)
A single-stage minimally invasive approach for synchronous left atrial myxoma and pulmonary atypical carcinoid is feasible and effective, offering a risk-adapted alternative to staged procedures.
Single-stage minimally invasive resection may be feasible in select synchronous cases; leaves open questions on safety, reproducibility, and outcomes.
Synchronous primary cardiac and pulmonary tumors are rare, presenting complex therapeutic challenges regarding surgical sequencing and perioperative risk. A 52-year-old man with atrial fibrillation was incidentally diagnosed with a left atrial myxoma and a suspicious left upper lobe hilar mass. Following multidisciplinary evaluation, a single-stage minimally invasive approach was performed. The procedure involved a right mini-thoracotomy for atrial myxoma resection under cardiopulmonary bypass, followed immediately by video-assisted thoracoscopic left upper lobectomy with systematic lymph node dissection. Pathology confirmed atrial myxoma and stage IB (pT2aN0M0) pulmonary atypical carcinoid. The postoperative course was uneventful; the patient remains disease-free at 36 months. In selected patients, simultaneous minimally invasive cardiothoracic resection is feasible and effective. This integrated strategy addresses competing risks-such as systemic embolization and oncologic progression-in a single setting, supporting a risk-adapted alternative to traditional staged approaches.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) conducted a case report in Synchronous left atrial myxoma and pulmonary atypical carcinoid (n=1). Single-stage minimally invasive resection was evaluated on Postoperative course and disease-free survival. Single-stage minimally invasive resection of synchronous left atrial myxoma and pulmonary atypical carcinoid was feasible and effective, with the patient remaining disease-free at 36 months.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: